公开(公告)号：US20190282692A1

公开(公告)日：2019-09-19

申请号：US15921945

申请日：2018-03-15

申请人： Reinhard Bredehorst ,  Thomas Grunwald ,  Markus Ollert ,  Carsten Schmidt-Weber ,  Edzard Spillner

发明人： Reinhard Bredehorst ,  Thomas Grunwald ,  Markus Ollert ,  Carsten Schmidt-Weber ,  Edzard Spillner

IPC分类号： A61K39/39 ,  A61K39/35 ,  A61K38/20 ,  C12N15/113 ,  A61K9/127 ,  A61K47/34 ,  A61K39/00 ,  A61K9/06 ,  A61K39/395 ,  A61K31/713

摘要： The invention relates to a pharmaceutical composition for the modulation of T cell and B cell responses made of one or more preparations and comprising a therapeutically effective dose of at least one inhibitor of TNFR1-mediated functions and of at least one antigen or allergen.

公开(公告)号：US20220273791A1

公开(公告)日：2022-09-01

申请号：US17491853

申请日：2021-10-01

申请人： Reinhard Bredehorst ,  Thomas Grunwald ,  Markus Ollert ,  Carsten Schmidt-Weber ,  Edzard Spillner

发明人： Reinhard Bredehorst ,  Thomas Grunwald ,  Markus Ollert ,  Carsten Schmidt-Weber ,  Edzard Spillner

IPC分类号： A61K39/39 ,  A61K39/395 ,  A61K31/713 ,  A61K38/20 ,  A61K39/35 ,  C12N15/113 ,  A61K9/06 ,  A61K9/127 ,  A61K39/00 ,  A61K47/34

摘要： The invention relates to a pharmaceutical composition for the modulation of T cell and B cell responses made of one or more prepatations and comprising a therapeutically effective dose of at least one inhibitor of TNFR1-mediated functions and of at least one antigen or allergen.